Compare GSK Consumer with KAVERI SEED - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK CONSUMER vs KAVERI SEED - Comparison Results

GSK CONSUMER     Change

GSK Consumer dominates the Rs 26 bn Indian malted beverage market with a significant 70% share (in volume terms). Its white beverage brand 'Horlicks' pioneered the broadening of the malted beverage market in India. Horlicks alone, as a white beverage... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK CONSUMER KAVERI SEED GSK CONSUMER/
KAVERI SEED
 
P/E (TTM) x 39.1 11.5 340.5% View Chart
P/BV x 11.0 3.7 298.4% View Chart
Dividend Yield % 1.0 0.6 177.0%  

Financials

 GSK CONSUMER   KAVERI SEED
EQUITY SHARE DATA
    GSK CONSUMER
Mar-19
KAVERI SEED
Mar-18
GSK CONSUMER/
KAVERI SEED
5-Yr Chart
Click to enlarge
High Rs7,819704 1,110.7%   
Low Rs5,832468 1,247.4%   
Sales per share (Unadj.) Rs1,136.9124.0 917.2%  
Earnings per share (Unadj.) Rs233.732.0 730.5%  
Cash flow per share (Unadj.) Rs248.135.8 693.2%  
Dividends per share (Unadj.) Rs105.003.00 3,500.0%  
Dividend yield (eoy) %1.50.5 300.4%  
Book value per share (Unadj.) Rs973.5153.2 635.5%  
Shares outstanding (eoy) m42.0666.09 63.6%   
Bonus/Rights/Conversions -B-  
Price / Sales ratio x6.04.7 127.0%   
Avg P/E ratio x29.218.3 159.5%  
P/CF ratio (eoy) x27.516.4 168.1%  
Price / Book Value ratio x7.03.8 183.4%  
Dividend payout %44.99.4 479.1%   
Avg Mkt Cap Rs m287,08338,712 741.6%   
No. of employees `0003.80.9 435.3%   
Total wages/salary Rs m6,446544 1,185.2%   
Avg. sales/employee Rs Th12,440.29,277.8 134.1%   
Avg. wages/employee Rs Th1,677.0616.0 272.2%   
Avg. net profit/employee Rs Th2,556.72,394.2 106.8%   
INCOME DATA
Net Sales Rs m47,8208,192 583.7%  
Other income Rs m4,326237 1,827.6%   
Total revenues Rs m52,1468,429 618.7%   
Gross profit Rs m11,4102,218 514.4%  
Depreciation Rs m606251 241.4%   
Interest Rs m86 130.0%   
Profit before tax Rs m15,1232,198 688.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,29584 6,303.5%   
Profit after tax Rs m9,8282,114 464.9%  
Gross profit margin %23.927.1 88.1%  
Effective tax rate %35.03.8 916.2%   
Net profit margin %20.625.8 79.6%  
BALANCE SHEET DATA
Current assets Rs m52,67411,824 445.5%   
Current liabilities Rs m18,1404,199 432.0%   
Net working cap to sales %72.293.1 77.6%  
Current ratio x2.92.8 103.1%  
Inventory Days Days36197 18.0%  
Debtors Days Days2938 76.9%  
Net fixed assets Rs m4,7982,234 214.8%   
Share capital Rs m421132 318.2%   
"Free" reserves Rs m40,5279,992 405.6%   
Net worth Rs m40,94710,124 404.5%   
Long term debt Rs m029 0.0%   
Total assets Rs m60,68114,487 418.9%  
Interest coverage x1,939.8367.4 528.1%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.6 139.4%   
Return on assets %16.214.6 110.8%  
Return on equity %24.020.9 114.9%  
Return on capital %37.021.7 170.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3,171131 2,423.7%   
Fx outflow Rs m1,77014 12,634.2%   
Net fx Rs m1,401117 1,199.1%   
CASH FLOW
From Operations Rs m6,7111,508 445.0%  
From Investments Rs m-3,351683 -490.4%  
From Financial Activity Rs m-3,768-2,262 166.6%  
Net Cashflow Rs m-408-71 576.8%  

Share Holding

Indian Promoters % 0.0 57.6 -  
Foreign collaborators % 72.5 0.0 -  
Indian inst/Mut Fund % 0.8 9.3 8.6%  
FIIs % 12.0 18.9 63.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 14.8 14.1 105.0%  
Shareholders   26,457 12,876 205.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK CONSUMER With:   HERITAGE FOOD  UNITED SPIRITS  GUJ.AMB.EXP.  ADVANTA.  TATA COFFEE  

Compare GSK CONSUMER With:   NESTLE (Switz.)  TIGER BRANDS (S. Africa)  COCA COLA (US)  AVI LTD. (S. Africa)  



Today's Market

Sensex Ends 377 Points Higher; Banking and Finance Stocks Rally(Closing)

After opening the day on a flat note, share markets in India extended gains as the session progressed and ended on a strong note, lifted by gains in financials and FMCG stocks.

Related Views on News

KAVERI SEED Announces Quarterly Results (1QFY21); Net Profit Up 28.7% (Quarterly Result Update)

Sep 14, 2020 | Updated on Sep 14, 2020

For the quarter ended June 2020, KAVERI SEED has posted a net profit of Rs 3 bn (up 28.7% YoY). Sales on the other hand came in at Rs 7 bn (up 14.6% YoY). Read on for a complete analysis of KAVERI SEED's quarterly results.

GSK CONSUMER Announces Quarterly Results (3QFY20); Net Profit Up 25.1% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 25.1% YoY). Sales on the other hand came in at Rs 12 bn (up 3.8% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

GSK CONSUMER Announces Quarterly Results (2QFY20); Net Profit Up 25.3% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 25.3% YoY). Sales on the other hand came in at Rs 13 bn (up 5.7% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

KAVERI SEED Announces Quarterly Results (1QFY20); Net Profit Up 9.3% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, KAVERI SEED has posted a net profit of Rs 2 bn (up 9.3% YoY). Sales on the other hand came in at Rs 6 bn (up 7.9% YoY). Read on for a complete analysis of KAVERI SEED's quarterly results.

GSK CONSUMER Announces Quarterly Results (1QFY20); Net Profit Up 23.8% (Quarterly Result Update)

Aug 5, 2019 | Updated on Aug 5, 2019

For the quarter ended June 2019, GSK CONSUMER has posted a net profit of Rs 2 bn (up 23.8% YoY). Sales on the other hand came in at Rs 12 bn (up 7.9% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

More Views on News

Most Popular

My View on ITC(Fast Profits Daily)

Oct 23, 2020

What do the charts say about ITC?

Why ITC and not HUL is my Idea of a Good Investment Right Now(Views On News)

Oct 15, 2020

Rahul Shah discusses HUL's lost decade and its implications for ITC.

Why India's Drone Revolution is a 4x Profit Opportunity(Profit Hunter)

Oct 16, 2020

My research on India's leading defence companies brought me to one major player in drone manufacturing.

The Biggest Wealth Creating Opportunity that No One is Talking About(Profit Hunter)

Oct 14, 2020

The defence sector has gone under the radar despite positive developments. Here's why this sector can't be ignored for long...

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

GSK CONSUMER SHARE PRICE


Apr 15, 2020 (Close)

TRACK GSK CONSUMER

  • Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK CONSUMER 5-YR ANALYSIS

COMPARE GSK CONSUMER WITH

MARKET STATS